These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2. Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564 [TBL] [Abstract][Full Text] [Related]
26. Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. Yamaguchi N; Chakraborty A; Pasek DA; Molkentin JD; Meissner G Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2187-95. PubMed ID: 21421818 [TBL] [Abstract][Full Text] [Related]
27. Stabilizing cardiac ryanodine receptor with dantrolene treatment prevents left ventricular remodeling in pressure-overloaded heart failure mice. Yano Y; Kobayashi S; Uchida T; Chang Y; Nawata J; Fujii S; Nakamura Y; Suetomi T; Uchinoumi H; Oda T; Yamamoto T; Yano M Biochem Biophys Res Commun; 2023 Jan; 642():175-184. PubMed ID: 36584481 [TBL] [Abstract][Full Text] [Related]
28. Diminished inhibition and facilitated activation of RyR2-mediated Ca Søndergaard MT; Liu Y; Brohus M; Guo W; Nani A; Carvajal C; Fill M; Overgaard MT; Chen SRW FEBS J; 2019 Nov; 286(22):4554-4578. PubMed ID: 31230402 [TBL] [Abstract][Full Text] [Related]
29. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167 [TBL] [Abstract][Full Text] [Related]
30. Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2. Alvarado FJ; Bos JM; Yuchi Z; Valdivia CR; Hernández JJ; Zhao YT; Henderlong DS; Chen Y; Booher TR; Marcou CA; Van Petegem F; Ackerman MJ; Valdivia HH JCI Insight; 2019 Mar; 5(7):. PubMed ID: 30835254 [TBL] [Abstract][Full Text] [Related]
31. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model. van Oort RJ; Respress JL; Li N; Reynolds C; De Almeida AC; Skapura DG; De Windt LJ; Wehrens XH Hypertension; 2010 Apr; 55(4):932-8. PubMed ID: 20157052 [TBL] [Abstract][Full Text] [Related]
32. S100A1 and calmodulin regulation of ryanodine receptor in striated muscle. Prosser BL; Hernández-Ochoa EO; Schneider MF Cell Calcium; 2011 Oct; 50(4):323-31. PubMed ID: 21784520 [TBL] [Abstract][Full Text] [Related]
33. The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor. Holt C; Hamborg L; Lau K; Brohus M; Sørensen AB; Larsen KT; Sommer C; Van Petegem F; Overgaard MT; Wimmer R J Biol Chem; 2020 May; 295(22):7620-7634. PubMed ID: 32317284 [TBL] [Abstract][Full Text] [Related]
34. mTOR signaling in mice with dysfunctional cardiac ryanodine receptor ion channel. Huang TQ; Zou MX; Pasek DA; Meissner G J Receptor Ligand Channel Res; 2015; 8():43-51. PubMed ID: 26312014 [TBL] [Abstract][Full Text] [Related]
35. Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia. Nakamura Y; Yamamoto T; Kobayashi S; Tamitani M; Hamada Y; Fukui G; Xu X; Nishimura S; Kato T; Uchinoumi H; Oda T; Okuda S; Yano M JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167968 [TBL] [Abstract][Full Text] [Related]
36. Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin. Oda T; Yamamoto T; Kato T; Uchinoumi H; Fukui G; Hamada Y; Nanno T; Ishiguchi H; Nakamura Y; Okamoto Y; Kono M; Okuda S; Kobayashi S; Bers DM; Yano M J Mol Cell Cardiol; 2018 Dec; 125():87-97. PubMed ID: 30359562 [TBL] [Abstract][Full Text] [Related]
37. Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814. Walweel K; Gomez-Hurtado N; Rebbeck RT; Oo YW; Beard NA; Molenaar P; Dos Remedios C; van Helden DF; Cornea RL; Knollmann BC; Laver DR J Mol Cell Cardiol; 2019 May; 130():96-106. PubMed ID: 30928430 [TBL] [Abstract][Full Text] [Related]
38. Role of cardiac ryanodine receptor calmodulin-binding domains in mediating the action of arrhythmogenic calmodulin N-domain mutation N54I. Søndergaard MT; Liu Y; Guo W; Wei J; Wang R; Brohus M; Overgaard MT; Chen SRW FEBS J; 2020 Jun; 287(11):2256-2280. PubMed ID: 31763755 [TBL] [Abstract][Full Text] [Related]
39. Arrhythmogenic calmodulin E105A mutation alters cardiac RyR2 regulation leading to cardiac dysfunction in zebrafish. Da'as SI; Thanassoulas A; Calver BL; Beck K; Salem R; Saleh A; Kontogianni I; Al-Maraghi A; Nasrallah GK; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M Ann N Y Acad Sci; 2019 Jul; 1448(1):19-29. PubMed ID: 30937913 [TBL] [Abstract][Full Text] [Related]
40. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology. Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]